SLGL

Sol-Gel Technologies Ltd.

A maker of topical creams for skin conditions, this Israeli pharmaceutical company develops treatments for acne, rosacea, and rare diseases like Gorlin syndrome, using a silica-based technology that releases active ingredients slowly through the skin. Founded in 1997 by Dr. Alon Seri-Levy in Ness Ziona, it takes its unusual name from the sol-gel process—the chemical method behind its microencapsulation technology, where a liquid "sol" turns into a "gel." Its approved products include Twyneo for acne and Epsolay for rosacea.

No proxy statement recorded.